Allele frequencies of 25 polymorphisms pertaining to cancer risk for Japanese, Koreans and Chinese

Asian Pacific Journal of Cancer Prevention

Volumn 3, Issue 3, 2002, Pages 197-206

  Hamajima, Nobuyuki ^a   Takezaki, Toshiro ^a   Tajima, Kazuo ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Allele frequency; Cancer; Chinese; Japanese; Koreans; Polymorphisms

Indexed keywords

EID: 0042355851     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Review

References (135)

1. Ambrosone CB, Freudenheim JL, Graham S, et al. (1996). Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA, 276, 1494-501.
2. Baek WK, Cho JW, Suh SI et al. (2000). p53 codon 72 polymorphism and risk of cervical carcinoma in Korean women. J Korean Med Sci, 15, 65-7.
3. Bartsch H, Nair U, Risch A, et al. (2000). Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev, 9, 3-28.
4. Butkiewicz D, Rusin M, Enewold L, et al. (2001). Genetic polymorphisms in DNA repair genes and risk of lung cancer. Carcinogenesis, 22, 593-7.
5. Chao YC, Wang LS, Hsieh TY, et al. (2000). Chinese alcoholic patients with esophageal cancer are genetically different from alcoholic with acute pancreatitis and liver cirrhosis. Am J Gastroenterol, 95, 2958-64.
6. Chen J, Giovannucci E, Hankinson SE, et al. (1998). A prospective study of methylenetetrahydrofolate reductase and methionine systhase gene polymorphisms, and risk of colorectal adenoma. Carcinogenesis, 19, 2129-32.
7. Chen S, Xue K, Xu L, Ma G, Wu J (2001). Polymorphisms of the CYP1A1 and GSTM1 genes in relation to individual susceptibility to lung cancer carcinoma in Chinese population. Mutat Res, 458, 41-7.
8. Chouchane L, Ahmed SB, Baccouche S, Remadi S (1997). Polymorphism in the tumor necrosis factor-α promotor region and in the heat chock protein 70 genes associated with malignant tumors. Cancer, 80, 1489-96.
9. Dunning AM, Healey CS, Pharoah PDP, et al. (1998). No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer. Br J Cancer, 77, 2045-7.
10. El-Omar EM, Carrington M, Chow W-H, et al. (2000). Interleukin-1 polymorphisms associated with increased risk of gastriccancer. Nature, 404: 398-402. Corrections 2001; 412: 99.
11. Fan R, Wu M-T, Miller D, et al. (2000). The p53 codon 72 polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev, 9, 1037-42.
12. Feigelson HS, Coetzee GA, Kolonel LN, Ross RK, Henderson BE (1997). A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res, 57, 1063-5.
13. Fronhoffs S, Bruning T, Ortiz-Pallardo E, et al. (2001). Real-time PCR analysis of the N-acetyltransferase NAT1 allele *3, *4, *10, *11, *14 and *17 polymorphism in squamous cell cancer of head and neck. Carcinogenesis, 22, 1405-12.
14. Gao C, Takezaki T, Wu J, et al. (2002). Interaction between cytochrome P-450 2E1 polymorphisms and environmental factors with risk of esophageal and stomach cancers in Chinese. Cancer Epidemiol Biomarkers Prev, 11, 29-34.
15. Garte S, Gaspari L, Alexandrie A-K, et al. (2001). Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev, 10, 1239-49.
16. Gertig DM, Hankinson SE, Hough H et al. (1999). N-acetyl transferase 2 genotypes, meat intake and breast cancer risk. Int J Cancer, 80, 13-7.
17. Goedde HW, Agarwal DP, Fritze G, et al. (1992). Distribution of ADH2 and ALDH2 genotypes in different populations. Hum Genet, 88, 344-6.
18. Guimaraes DP, Lu SH, Snijders P, et al. (2001). Absence of association between HPV DNA, TP53 codon 72 polymorphism, and risk of oesophageal cancer in a high-risk area in China. Cancer Lett, 162, 231-5.
19. Hachiya T, Kuriaki Y, Ueoka Y, et al. (1999). WAF1 genotype and endometrial cancer susceptibility. Gynecol Oncol, 72, 187-92.
20. Haiman CA, Hankinson SE, Spiegelman D, et al. (1999). The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Res, 59, 1015-20.
21. Hamajima N, Yuasa H, Matsuo K, Kurobe Y (1999) Detection of gene-environment interaction by case-only studies. Jpn J Clin Oncol, 29, 490-93.
22. Hamajima N, Iwata H, Obata Y, et al. (2000). No association of the 5' promoter region polymorphism of CYP17 with breast cancer risk in Japan. Jpn J Cancer Res, 91, 880-5.
23. Hamajima N, Matsuo K, Tajima K, et al. (2001a). Limited association between a catechol-O-methyltransferase (COMT) polymorphism and breast cancer in Japan. Int J Clin Oncol, 6, 13-8.
24. Hamajima N, Matsuo K, Saito T, et al. (2001b). Interleukin 1 polymorphisms, lifestyle factors, and Helicobacter pylori infection. Jpn J Cancer Res, 92, 383-9.
25. Hamajima N, Ito H, Matsuo K, et al. (2002a). Helicobacter pylori seropositivity, interleukin 1B polymorphism, and smoking among first-visit outpatients. Asian Pacific J Cancer Prev, 3, 23-8.
26. Hamajima N, Matsuo K, Iwata H, et al. (2002b). NAD(P)H: quinine oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese. Int J Clin Oncol, 7, 103-8.
27. Hamajima N, Saito T, Matsuo K, et al. (2002 c). Genetic frequencies of 50 polymorphisms for 241 Japanese non-cancer patients. J Epidemiol, 12, 229-36.
28. Hein DW, Doll MA, Fretland AJ, et al. (2000). Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev, 9, 29-42.
29. Herrington DM, Howard TD, Hawkins GA, et al. (2002). Estrogenreceptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronarydisease. N Engl J Med, 346, 967-74.
30. Hessner MJ, Luhm RA, Pearson SL, et al. (1999). Prevalence of prothrombin G20210A, factor V G1691A (Leiden), and methylenetetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiplex allele-specific PCR. Throm Haemost, 81, 733-8.
31. Hong YS, Chang JH, Kwon OJ, Ham YA, Choi JH (1998). Polymorphism of the CYP1A1 and glutathione-S-transferase gene in Korean lung cancer patients. Exp Mol Med, 30, 192-8.
32. Hoshino S, Hosoi T, Miyao M, et al. (2000). Identification of a novel polymorphism of estrogen receptor-α gene that is associated with calcium excretion in urine. J Bone Miner Metab, 18, 153-7.
33. Hsieh F-I, Pu Y-S, Chern H-D, et al. (1999). Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smokingrelated bladder cancer. Br J Cancer, 81, 537-41.
34. Hsieh Y-Y, Chang C-C, Tsai F-J, et al. (2001). Polymorphisms for interleukin-1β (IL-1β)-511 promoter, IL-1β exon 5, and IL-1 receptor antagonist: nonassociation with endometeriosis. J Assis Reprod Genet, 18, 506-11.
35. Houlston RS (1999). Glutathione S-transferase M1 status and lung cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev, 8, 675-82.
36. Houlston RS (2000). CYP1A1 polymorphisms and lung cancer risk: a meta-analysis. Pharmacogenetics, 10, 105-14.
37. Huang CS, Chern HD, Chang KJ, et al. (1999). Breast cancer risk associated with genotype polymorphism of the estrogenmetabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res, 59, 4870-5.
38. Hulkkonen J, Laippala P, Hurme M. (2000). A rare allele combination of the interleukin-1 gene complex is associated with high interleukin-1β plasma levels in healthy individuals. Eur Cytokine Netw, 11, 251-5.
39. Inoue H, Kiyohara C, Marugame T, et al. (2000). Cigarette smoking, CYP1A1 MspI and GSTM1 genotypes, and colorectal adenomas. Cancer Res, 60, 3749-52.
40. Ito LS, Iwata H, Hamajima N, et al. (2002a). Significant reduction in breast cancer risk for Japanese women with interleukin 1B -31 CT/.TT relative to CC genotype. Jpn J Clin Oncol (in press).
41. Ito H, Hamajima N, Takezaki T, et al. (2002b) A limited association of hOGG1 Ser326Cys polymorphism for adenocarcinoma of the lung. J Epidemiol, 12, 258-65.
42. Kadlubar FF, Badawi AF (1995). Genetic susceptibility and carcinogen-DNA adduct formation in human urinary bladder carcinogenesis. Toxicol Lett, 82, 627-32.
43. Kamizono S, Hiromatsu Y, Seki N, et al. (2000). A polymorphism of the 5' flanking region of tumour necrosis factor Éø gene is associated with thyroid-associated ophthalmopathy in Japanese. Clin Endocrinol, 52, 759-64.
44. Kang HJ, Kim SW, Kim HJ, et al. (2002). Polymorphisms in the estrogen receptor-alpha gene and breast cancer risk. Cancer Lett, 25, 175-80.
45. Kato S, Onda M, Yamada S, et al. (2001). Association of the interleukin-1β genetic polymorphism and gastric cancer risk in Japanese. J Gastroenterol, 36, 696-9.
46. Katoh T, Nagata N, Kuroda Y, et al. (1996). Glutathione Stransferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis, 17, 1855-9.
47. Katoh T, Kaneko S, Boissy R, et al. (1998). A pilot study testing the association between N-acetyltransferases 1 and 2 and risk of oral squamous cell carcinoma in Japanese people.Carcinogenesis, 19, 1803-7.
48. Kawajiri K, Fujii-Kuriyama Y (1991). P450 and human cancer. Jpn J Cancer Res, 82, 1325-35.
49. Kihara M, Kihara M, Noda K (1994). Lung cancer risk of GSTM1 null genotype is dependent on the extent of tobacco smoke exposure. Carcinogenesis, 15, 415-8.
50. Kihara M Kihara M, Noda K (1999). Lung cancer risk of the GSTM1 null genotype is enhanced in the presence of the GSTP1 mutated genotype in male Japanese smokers. Cancer Lett, 137, 53-60.
51. Kim KS, Ryu SW, Kim YJ, Kim E (1999). Polymorphism analysis of the CYP1A1 locus in Koreans: presence of the solitary m2 allele. Mol Cells, 9, 78-83.
52. Kim W-J, Lee H-L, Lee S-C, et al. (2000). Polymorphisms of Nacetyltransferase 2, glutathione S-transferase Mu and Theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis. J Urol, 164, 209-13.
53. Kim JW, Roh JW, Park NH, et al. (2001). Polymorphism of TP53 codon 72 and the risk of cervical cancer among Korean women. Am J Obstet Gynecol, 184, 55-8.
54. Kim S-U, Park S K, Yoo K-Y, et al. (2002). XRCC1 genetic polymorphism and breast cancer risk. Pharmacogenetics, 12, 335-8.
55. Kiyohara C (2000). Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of colorectal cancer. J Epidemiol, 10, 349-60.
56. Krajinovic M, Sinnett H, Richer C, et al. (2002). Role of NQO1, MPO, and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Int J Cancer, 97, 230-6.
57. Kunstman E, Epplen C, Elitok E, et al. (1999). Helicobacter pylori infection and polymorphisms in the tumor necrosis factor region. Electrophoresis, 20, 1756-61.
58. Lavigne H, Helzlsouer K, Huang H-Y, et al. (1997). An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk of for breast cancer. Cancer Res, 57, 5493-7.
59. Le Marchand L, Donlon T, Lum-Jones A, Seifriend A, Wilkens LR. (2002). Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiol Biomarkers Prev, 11, 409-12.
60. Lee KH, Kwak BY, Kim JH, et al. (1997a). Genetic polymorphism of cytochrome P-4502E1 and mitochondrial aldehyde dehydrogenase in a Korean population. Alcohol Clin Exp Res, 21, 953-6.
61. Lee H-S, Yoon J-H, Kamimura S, et al. (1997b). Lack of association of cytochrome P450 2E1 genetic polymorphisms with the risk of human hepatocellular carcinoma. Int J Cancer, 71, 737-40.
62. Lee J-M, Lee Y-C, Yang S-Y, et al. (2000). Genetic polymorphisms of p53 and GSTP1, but not NAT2, are associated with susceptibility ot squamous-cell carcinoma of the esophagus. Int J Cancer, 89, 458-64.
63. Lin P, Wang H-J, Lee H, et al. (1999). NAD(P)H:quinine oxidoreductase polymorphism and lung cancer in Taiwan. J Toxicol Environ Health, Part A, 58, 187-97.
64. Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA (1999). XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res, 59, 2557-61.
65. Ma J, Stampher MJ, Giovannucci E, et al. (1997). Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res, 57, 1098-102.
66. Mansfield JC, Holden H, Tarlow JK, et al. (1994). Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterol, 106, 637-42.
67. Matsuo K, Hamajima N, Shinoda M, et al. (2001a). Geneenvironment interaction between aldehyde dehydrogenase-2 (ALDH2) polymorphism and alcohol consumption for the risk of esophageal cancer. Carcinogenesis, 22, 913-6.
68. Matsuo K, Suzuki R, Hamajima N, et al. (2001b). Association between polymorphisms of folate and methionine metabolizing enzymes and susceptibility to malignant lymphoma. Blood, 97, 3205-9.
69. Matsuo K, Hamajima N, Hirai T, et al. (2002). Aldehyde dehydrogenase 2 (ALDH2) genotype affects rectal cancer susceptibility due to alcohol consumption. J Epidemiol, 12, 70-6.
70. Millikan RC, Pittman GS, Tse C-KJ, et al. (1998). Catechol-Omethyltransferase and breast cancer risk. Carcinogenesis, 19, 1943-1947.
71. Millikan R, Pittman G, Tse C-K, et al. (2000). Glutathione Stransferase M1, T1, and P1 and breast cancer. Cancer Epidemiol Biomarkers Prev, 9, 567-573.
72. Minaguchi T, Kanamori Y, Matsushima M, et al. (1998). No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection. Cancer Res, 58, 4585-6.
73. Miyoshi Y, Iwao K, Ikeda N, Egawa C, Noguchi S (2000). Genetic polymorphism in CYP17 and breast cancer risk in Japanese women. Eur J Cancer, 36, 2375-9.
74. Morita H, Taguchi J, Kurihara H, et al. (1997). Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation, 95, 2032-6.
75. Morita S, Yano M, Tsujinaka T, et al. (1998). Association between genetic polymorphisms of glutathione S-transferase P1 and Nacetyltransferase 2 and susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer, 79, 517-20.
76. Murata M, Watanabe M, Yamanaka M, et al. (2001). Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population. Cancer Lett, 165, 171-7.
77. Nakachi K, Imai K, Hayashi S, Watanabe J, Kawajiri K (1991). Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res, 51, 5177-80.
78. Nakachi K, Imai K, Hayashi S, Kawajiri K (1993). Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in Japanese population. Cancer Res, 53, 2994-9.
79. Naoe T, Takeyama K, Yokozawa T, et al. (2000). Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/ myelodysplastic syndrome and de novo acute myeloid leukemia. Clin Cancer Res, 6, 4091-5.
80. Nelson DR, Koymans L, Kamataki T, et al. (1996). P450 super family: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics, 6, 1-42.
81. Nishimura M, Mizuta I, Mizuta E, et al. (2000). Influence of interleukin-1β gene polymorphisms on age-at-onset sporadic Parkinson's disease. Neurosci Lett, 284, 73-6.
82. Ohara K, Nagai M, Suzuki Y, et al. (1998). Low activity allele of catechol-o-methyltransferase gene and Japanese unipolardepression. Neuro Report, 9, 1305-8.
83. Oyama T, Kawamoto T, Mizoue T, et al. (1997a). P53 mutations of lung cancer are not significantly affected by CYP1A1 or GSTM1 polymorphisms. Int J Oncol, 11, 305-9.
84. Oyama T, Kawamoto T, Mizoue T, et al. (1997b). Cytochrome P450 2E1 polymorphism as a risk factor for lung cancer: in relation to p53 gene mutation. Anticancer Res, 17, 583-8.
85. Oyama T, Kawamoto T, Mizoue T, et al. (1997c). N-acetylation polymorphism in patients with lung cancer and its association with p53 gene mutation. Anticancer Res, 17, 577-82.
86. Park S-K, Yoo K-Y, Lee S-J, et al. (2000). Alcohol consumption, glutathione S-transferase M1 and T1 genetic polymorphisms and breast cancer risk. Pharmacogenetics, 10: 301-9.
87. Pearce CL, Makridakis NM, Ross RK, et al. (2002). Steroid 5-〈 reductase type II V89L substitution is not associated with risk of prostate cancer in a multiethnic population study. Cancer Epidemiol Biomarkers Prev, 11, 417-8.
88. Pierce LM, Sivaraman L, Chang W, et al. (2000). Relationships of TP53 codon 72 and HRAS polymorphisms with lung cancer risk in an ethnically diverse population. Cancer Epidemiol Biomarkers Prev, 9, 1199-204.
89. Rasmussen SK, Urhammer SA, Jensen JN, et al. (2000). The -234 and -308 G->A polymorphisms of the tumor necrosis factor alpha gene promoter are not associated with features of the insulin resistence syndrome or altered birth weight in Danish Caucasians. J Clin Endocrinol Metab, 85, 1731-4.
90. Rebbeck TR (1997). Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev, 6, 733-43.
91. Roh J, Kim M, Kim J, et al. (2001). Polymorphisms in codon 31 of p21 and cervical cancer susceptibility in Korean women. Cancer Lett, 10, 59-62.
92. Roodi N, Bailey LR, Kao W-Y, et al. (1995). Estrogen receptor gene analysis in estrogen receptor-positive and receptornegative primary breast cancer. J Natl Cancer Inst, 87, 446-51.
93. Rosvold EA, McGlynn KA, Lustbader ED, Buetow KH (1995). Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking. Pharmacogenetics, 5, 199-206.
94. Seow A, Zhao B, Poh W-T, et al. (1999). NAT2 slow acetylator genotype is associated with increased risk of lung cancer among non-smoking Chinese women in Singapore. Carcinogenesis, 20, 1877-81.
95. Setiawan VW, Zhang Z-F, Yu G-P, et al. (2001a). GSTT1 and GSTM1 null genotypes and the risk of gastric cancer: a casecontrol study in a Chinese population. Cancer Epidemiol Biomarkers Prev, 9, 73-80.
96. Setiawan VW, Zhang ZF, Yu GP, et al. (2001b). GSTP1 polymorphisms and gastric cancer in a high-risk Chinese population. Cancer Causes Control, 12, 673-81.
97. Shen YC Fan JH, Edenberg HJ et al. (1997). Polymorphism of ADH and ALDH genes among four ethnic groups in China and effects upon the risk for alcoholism. Alcohol Clin Exp Res, 21, 1272-7.
98. Shen H, Xu Y, Qian Y, et al. (2000). Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a chinese population. Int J Cancer, 88, 601-6.
99. Shen H, Xu Y, Zheng Y, et al. (2001). Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study. Int J Cancer, 95, 332-6.
100. Sheu WH, Lee WJ, Lin LY, Chang RL, Chen YT (2001). Tumor necrosis factor alpha -238 and -308 polymorphisms do no associate with insulin resistence in hypertensive subjects. Metabolism, 50, 1447-51.
101. Shih CM, Lin P-T, Wang H-C, et al. (2000). Lack of evidence of association of p21WAF1/CIP1 polymorphism with lung cancer susceptibility and prognosis in Taiwan. Jpn J Cancer Res, 91, 9-15.
102. Sjalander A, Birgander R Rannug A, et al. (1996). Association between the p21 codon 31 A1 (arg) allele and lung cancer. Hum Hered, 46, 221-5.
103. Skibola CF, Smith MT, Kane E, et al. (1999). Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA, 96, 12810-5.
104. Slattery ML, Potter JD, Samowitz W, et al. (1998). NAT2, GSTM-1, cigarette smoking, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev, 7, 1079-84.
105. Smith MT, Wang Y, Kane E, et al. (2001). Low NAD(P)H:quinine oxidoreductase 1 activity is associated with incrased risk of acute leukemia in adults. Blood, 97, 1422-6.
106. Song C, Tan W, Xing D, Lin D (2001a). CYP1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a casecontrol study in China. Carcinogenesis, 22, 11-6.
107. Song C, Xing D, Tan W, Wei Q, Lin D (2001b). Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res, 61, 3272-5.
108. Southey MC, Batten LE, McCredie MRE, et al. (1998). Estrogen receptor polymorphism at codon 325 and risk of breast cancer in women before age forty. J Natl Cancer Res, 90, 532-6.
109. Sturgis EM, Castillo EJ, Li Lei, et al. (1999). Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis, 20, 2125-9.
110. Sugimura H, Kohno T, Wakai K, et al. (1999). hOGG1 Ser326Cys polymorphism and lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev, 8, 669-74.
111. Takeshita T, Morimoto K, Mao X-Q, Hashimoto T, Furyuama J (1993). Phanotypic differences in low Km aldehyde dehydrogenase in Japanese workers. Lancet, 341, 837-8.
112. Takezaki T, Gao CM, Wu JZ, et al. (2002). hOGG1 Ser(326)Cys polymorphism and modification by environmental factors of stomach cancer risk in Chinese. Int J Cancer, 99, 624-7.
113. Tan W, Song N, Wang G-Q, et al. (2000). Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione Stransferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China. Cancer Epidemiol Biomarkers Prev, 9, 551-6.
114. Tang YM, Green BL, Chen GF, et al. (2000). Human CYP1B1 Leu432Val gene polymorphism: ethnic distribution in African-Americans, Caucasians and Chinese; oestrodiol hydroxylase activity; and distribution in prostate cancer cases and controls. Pharmacogenetics, 10, 761-6.
115. Taylor JA, Umbach DM, Stephens E, et al. (1998). The role of Nacetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction. Cancer Res, 58, 3603-10.
116. Thomas M, Kaltin A, Labrecque S, et al. (1999). Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol, 2, 1092-100.
117. Thompson PA, Shields PG, Freudenheim JL, et al. (1998). Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. Cancer Res, 58, 2107-10.
118. Tsai M-H, Chen W-C, Tsai F-J (2002). Correlation of p21 gene codon 31 polymorphism and TNF-α gene polymorphism with nasopharyngeal carcinoma. J Clin Lab Anal, 16, 146-50.
119. Tseng LH, Chen PJ, Lin MT, et al. (2001). Single nucleotide polymorphisms in intron 2 of the human interleukin-1 receptor antagonist (IL-1Ra) gene: further definition of the IL-1β and IL-1Ra polymorphisms in North American Caucasians and Taiwanese Chinese. Tissue Antigens, 57, 318-24.
120. Vineis P, Malats N, Lnag M, et al. (1999). Metabolic polymorphisms and susceptibility to cancer. IARC Scientific Publications No. 148, International Agency for Research on Cancer, Lyon.
121. Watanabe J, Yang J-P, Eguchi H, et al. (1995). An Rsa I polymorphism in the CYP2E1 gene does not affect lung cancer risk in a Japanese population. Jpn J Cancer Res, 86, 245-8.
122. Watanabe J, Shimada T, Gillam EMJ, et al. (2000). Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer. Pharmacogenetics, 20, 25-33.
123. Wang Y-C, Chen C-Y, Chen S-K, Chang Y-Y, Lin P (1999). p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis. Clin Cancer Res, 5, 129-34.
124. Wikman H, Risch A, Klimek F, et al. (2000) hOGG1 polymorphism and loss of heterozygosity (LOH): significance for lung cancer susceptibility in a Caucasian population. Int J Cancer, 88, 932-7.
125. Wikman H, Thiel S, Jager B, et al. (2001). Relevance of Nacetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility. Pharmacogenetics, 11, 157-68.
126. Wong R-H, Du C-L Wang J-D, et al. (2002). XRCC1 and CYP2E1 polymorphisms as susceptibility factors of plasma mutant p53 protein and anti-p53 antibody expression in vinyl chloride monomer-exposed polyvinyl chloride workers. Cancer Epidemiol Biomarkers Prev, 11, 475-82.
127. Xing DY, Tan W, Song N, Lin DX (2001). Ser326Cys polymorphism in hOGG1 gene and risk of esophageal cancer in a Chinese population. Int J Cancer, 95, 140-3.
128. Yang X, Takeshita T, Morimoto K (2000a). N-acetyltransferase polymorphism and human cancer risk. Environ Health Prev Med, 4, 165-73.
129. Yang M, Katoh T, Delongchamp R, et al. (2000b). Relationship between NAT1 genotype and phenotype in a Japanese population. Pharmacogenetics, 10, 225-32.
130. Yea SS, Yang Y-I, Jang WH, et al. (2001). Association between TNF-α promoter polymorphism and Helicobacter pylori cagA subtype infection. J Clin Pathol, 54, 703-6.
131. Yim D-S, Park S K, Yoo K-Y, et al. (2001). Relationship between the Val158Met polymorphism of catechol -methyl transferase and breast cancer. Pharmacogenetics, 11, 279-86.
132. Zehbe I, Voglino G, Wilander E, et al. (2001). P53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development. Cancer Res, 61, 608-11.
133. Zhao B, Seow A, Lee EJ, et al. (2001). Dietary isothiocyanates, glutathione S-transferase-M1, -T1 polymorphisms and lung cancer risk among Chinese women in Singapore. Cancer Epidemiol Biomarkers Prev, 10, 1063-7.
134. Zheng W, Xie D-W, Jin F, et al. (2000). Genetic polymorphism of cytochrome P450-1B1 and risk of breast cancer. Cancer Epidemiol Biomarkers Prev, 9, 147-50.
135. Zuo M, Lee MJ, Kim MH, et al. (1999). C677T mutation of the methylenetetrahydrofolate reductase gene among the Korean infants in Seoul city. Kobe J Med Sci, 45, 271-9.